These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 28663235)

  • 1. Immunotherapy of Prostate Cancer: Facts and Hopes.
    Bilusic M; Madan RA; Gulley JL
    Clin Cancer Res; 2017 Nov; 23(22):6764-6770. PubMed ID: 28663235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer, new treatment advances - immunotherapy.
    Silva D; Abreu-Mendes P; Mourato C; Martins D; Cruz R; Mendes F
    Actas Urol Esp (Engl Ed); 2020 Sep; 44(7):458-468. PubMed ID: 32473820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy for Localized Prostate Cancer: The Next Frontier?
    Patel D; McKay R; Parsons JK
    Urol Clin North Am; 2020 Nov; 47(4):443-456. PubMed ID: 33008495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolving role of immunotherapy in prostate cancer.
    Gerritsen WR
    Ann Oncol; 2012 Sep; 23 Suppl 8():viii22-7. PubMed ID: 22918924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer vaccines: current status and future potential.
    Doehn C; Böhmer T; Kausch I; Sommerauer M; Jocham D
    BioDrugs; 2008; 22(2):71-84. PubMed ID: 18345705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy in prostate cancer: review of the current evidence.
    Fernández-García EM; Vera-Badillo FE; Perez-Valderrama B; Matos-Pita AS; Duran I
    Clin Transl Oncol; 2015 May; 17(5):339-57. PubMed ID: 25480118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refining Immuno-Oncology Approaches in Metastatic Prostate Cancer: Transcending Current Limitations.
    Wong RL; Yu EY
    Curr Treat Options Oncol; 2021 Jan; 22(2):13. PubMed ID: 33433743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update: immunological strategies for prostate cancer.
    Drake CG; Antonarakis ES
    Curr Urol Rep; 2010 May; 11(3):202-7. PubMed ID: 20425628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy for prostate cancer: recent developments and future challenges.
    Schweizer MT; Drake CG
    Cancer Metastasis Rev; 2014 Sep; 33(2-3):641-55. PubMed ID: 24477411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for metastatic prostate cancer: immuno-cold or the tip of the iceberg?
    Laccetti AL; Subudhi SK
    Curr Opin Urol; 2017 Nov; 27(6):566-571. PubMed ID: 28825923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond sipuleucel-T: immune approaches to treating prostate cancer.
    Cheng ML; Fong L
    Curr Treat Options Oncol; 2014 Mar; 15(1):115-26. PubMed ID: 24402184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine--Dendreon.
    Drugs R D; 2006; 7(3):197-201. PubMed ID: 16752945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Not Available].
    Oudard S; Thibault C; Angelergues A; Tartour E; Timsit MO; Mejean A; Michel C; Vano Y
    Bull Cancer; 2016 Nov; 103 Suppl 1():S144-S150. PubMed ID: 28057178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for Prostate Cancer.
    Venturini NJ; Drake CG
    Cold Spring Harb Perspect Med; 2019 May; 9(5):. PubMed ID: 30201787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Era of Immunotherapy in Prostate Cancer.
    Pizzola C; Rizvi SM; Joshi M
    Curr Mol Pharmacol; 2016; 9(3):217-225. PubMed ID: 26177645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy in Prostate Cancer: Teaching an Old Dog New Tricks.
    Comiskey MC; Dallos MC; Drake CG
    Curr Oncol Rep; 2018 Aug; 20(9):75. PubMed ID: 30120592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy in prostate cancer.
    Sobol I; Thompson RH; Dong H; Krco C; Kwon ED
    Curr Urol Rep; 2015 Jun; 16(6):34. PubMed ID: 25894495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy and therapeutic vaccines in prostate cancer: an update on current strategies and clinical implications.
    Singh BH; Gulley JL
    Asian J Androl; 2014; 16(3):364-71. PubMed ID: 24435055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current immunotherapeutic strategies in prostate cancer.
    Grosso JF; Drake CG
    Surg Oncol Clin N Am; 2007 Oct; 16(4):861-71, x. PubMed ID: 18022549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising novel immunotherapies and combinations for prostate cancer.
    Arlen PM; Mohebtash M; Madan RA; Gulley JL
    Future Oncol; 2009 Mar; 5(2):187-96. PubMed ID: 19284377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.